Groove Botanicals (GRVE) Cash & Equivalents (2016)
Groove Botanicals' Cash & Equivalents history spans 7 years, with the latest figure at $126854.0 for Q4 2016.
- For Q4 2016, Cash & Equivalents fell 6.36% year-over-year to $126854.0; the TTM value through Dec 2016 reached $126854.0, down 6.36%, while the annual FY2016 figure was $108220.0, 20.26% down from the prior year.
- Cash & Equivalents for Q4 2016 was $126854.0 at Groove Botanicals, up from $106697.0 in the prior quarter.
- Across five years, Cash & Equivalents topped out at $321160.0 in Q2 2013 and bottomed at $106697.0 in Q3 2016.
- The 5-year median for Cash & Equivalents is $127836.0 (2015), against an average of $143789.2.
- The largest annual shift saw Cash & Equivalents plummeted 63.27% in 2012 before it soared 185.02% in 2013.
- A 5-year view of Cash & Equivalents shows it stood at $118773.0 in 2012, then dropped by 6.24% to $111365.0 in 2013, then increased by 6.18% to $118249.0 in 2014, then rose by 14.57% to $135477.0 in 2015, then decreased by 6.36% to $126854.0 in 2016.
- Per Business Quant, the three most recent readings for GRVE's Cash & Equivalents are $126854.0 (Q4 2016), $106697.0 (Q3 2016), and $107302.0 (Q2 2016).